Tirzepatide is a synthetic 39-amino acid peptide that functions as a dual agonist at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism distinguishes it from single-receptor GLP-1 agonists and has made it a subject of considerable scientific interest in metabolic and endocrinological research.
In preclinical and clinical research settings, tirzepatide has been studied for its effects on insulin secretion, glucagon suppression, gastric emptying, and appetite regulation. Its simultaneous engagement of both incretin receptors is hypothesised to produce additive or synergistic effects on glycaemic control and energy homeostasis, making it a valuable tool in obesity and type 2 diabetes research models.
Peptician supplies Tirzepatide at 20mg per vial as a lyophilised powder, with a purity of greater than 98% as verified by HPLC analysis.
For optimal stability, store lyophilised product at -20°C, protected from light and moisture. Once reconstituted, store at 4°C and use within 72 hours.
Molecular Formula
C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight
4813.5 g/mol
Purity
>98%
CAS Number
2023788-19-2
Form
Lyophilised Powder
Research Applications
Metabolic disorder research, glucose homeostasis studies, obesity and body composition research, incretin biology, insulin secretion modelling, appetite regulation studies
For research purposes only. Not for human use. This product is intended solely for in vitro and preclinical research applications by qualified professionals.
Reviews
There are no reviews yet.